Arvinas and Pfizer are jointly developing vepdegestrant for breast cancer and seeking FDA acceptance for the NDA.

The entities involved

• Arvinas (United States) →

  company in New Haven, United States

  • Trump pledged to unleash American oil and gas production, involving LCNB National Bank.Sun 03:20
• Pfizer →

  American multinational pharmaceutical and biotechnology corporation

  • Dave Long trained at Fort Knox after graduating from Boardman High School and later worked for Pfizer.Mon 05:00
  • MarketBeat's screener has identified a list of dividend stocks.Sun 22:22
• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56

Related events

• Cuong Do leads BioVie as its CEO. BioVie Inc is listed on the NASDAQ exchange and is seeking FDA review for its drug candidate.Aug 6
• BioXcel Therapeutics received FDA approval for its drug and announced results from New Haven.Jun 7
• The FDA issued a not-approvable letter for VenoValve, a medical device manufactured by enVVeno Medical Corporation.Jun 7
• Cardiol Therapeutics Inc. is listed on Nasdaq and is developing therapy for an FDA-approved indication.Wed 10:43
• Implantica AG secured FDA approval for its product RefluxStop, announced its successful listing on the Nasdaq First North Premier Growth Market, and is headquartered in Vaduz, Liechtenstein.Aug 25